These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12402070)

  • 41. Paclitaxel Carboplatin chemotherapy as a second-line chemotherapy for advanced platinum resistant urothelial cancer in Japanese cases.
    Soga N; Onishi T; Arima K; Sugimura Y
    Int J Urol; 2007 Sep; 14(9):828-32. PubMed ID: 17760750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer.
    Yamamoto R; Kaneuchi M; Nishiya M; Todo Y; Takeda M; Okamoto K; Negishi H; Sakuragi N; Fujimoto S; Hirano T
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):137-42. PubMed ID: 12172979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Taxol in the treatment of ovarian neoplasm].
    Wang Y; Huang R; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):439-41. PubMed ID: 11360659
    [No Abstract]   [Full Text] [Related]  

  • 47. Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients.
    Bruzzone M; Catsafados E; Miglietta L; Amoroso D; Pedulla F; Giannessi PG; Locatelli MC; D'Antona A; Foglia G; Mammoliti S; Turno F; Gentile A; Nicosia F; Luporini G; Ragni N; Boccardo F
    Oncology; 1996; 53(5):349-53. PubMed ID: 8784466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of platinum-containing chemotherapy on olfactory, gustatory, and hearing function in ovarian cancer patients.
    Steinbach S; Hundt W; Schmalfeldt B; Böhner C; Berktold S; Wolf P; Harbeck N
    Arch Gynecol Obstet; 2012 Aug; 286(2):473-80. PubMed ID: 22481492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment strategies in ovarian cancer].
    Puistola U; Leminen A
    Duodecim; 2013; 129(18):1917-24. PubMed ID: 24187783
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suicidal depression related to chemotherapy in a patient with ovarian cancer.
    Yeh YW; Chen CY; Kuo SC; Lin CK; Huang SY
    Psychosomatics; 2012; 53(1):98-100. PubMed ID: 22221729
    [No Abstract]   [Full Text] [Related]  

  • 51. Prophylactic effect of pemirolast, an antiallergic agent, against hypersensitivity reactions to paclitaxel in patients with ovarian cancer.
    Yahata H; Saito M; Sendo T; Itoh Y; Uchida M; Hirakawa T; Nakano H; Oishi R
    Int J Cancer; 2006 May; 118(10):2636-8. PubMed ID: 16353140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy: Current drugs still have potential in advanced ovarian cancer.
    Hogberg T
    Nat Rev Clin Oncol; 2010 Apr; 7(4):191-3. PubMed ID: 20354543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paclitaxel poliglumex for ovarian cancer.
    Galic VL; Wright JD; Lewin SN; Herzog TJ
    Expert Opin Investig Drugs; 2011 Jun; 20(6):813-21. PubMed ID: 21470062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study.
    Aravantinos G; Skarlos DV; Kosmidis P; Athanassiades A; Bafaloukos D; Giannakakis T; Karpathios S; Fountzilas G
    Eur J Cancer; 1997 Jan; 33(1):160-3. PubMed ID: 9071916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel.
    Bridgewater JA; Nelstrop AE; Rustin GJ; Gore ME; McGuire WP; Hoskins WJ
    J Clin Oncol; 1999 Feb; 17(2):501-8. PubMed ID: 10080591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma: a case report and review of literature.
    Shah K; Gupta S; Ghosh J; Bajpai J; Maheshwari A
    J Cancer Res Ther; 2012; 8(3):442-4. PubMed ID: 23174732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurotoxicity associated with a regimen of carboplatin (AUC 5-6) and paclitaxel (175 mg/m2 over 3 h) employed in the treatment of gynecologic malignancies.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    J Cancer Res Clin Oncol; 2001 Jan; 127(1):55-8. PubMed ID: 11206272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Usefulness of duloxetine for Paclitaxel-induced peripheral neuropathy treatment in gynecological cancer patients.
    Otake A; Yoshino K; Ueda Y; Sawada K; Mabuchi S; Kimura T; Kobayashi E; Isobe A; Egawa-Takata T; Matsuzaki S; Fujita M; Kimura T
    Anticancer Res; 2015 Jan; 35(1):359-63. PubMed ID: 25550572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localized toxic erythema of chemotherapy during treatment with paclitaxel.
    Spicknall KE; Mutasim DF
    Int J Dermatol; 2014 Jan; 53(1):e3-5. PubMed ID: 23451872
    [No Abstract]   [Full Text] [Related]  

  • 60. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.
    Dasanu CA; Alexandrescu DT
    South Med J; 2008 Nov; 101(11):1161-2. PubMed ID: 19088531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.